Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
Jiayu Holding
300117
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
600211 Tibet Rhodiola Pharmaceutical Holding
- 35.88
- -0.20-0.55%
Not Open Jan 22 15:00 CST
11.56BMarket Cap15.68P/E (TTM)
36.20High35.76Low13.38KlotVolume36.03Open36.08Pre Close48.04MTurnover0.42%Turnover Ratio14.44P/E (Static)322.32MShares44.8652wk High3.26P/B11.56BFloat Cap25.1652wk Low39.69Limit Up322.32MShs Float136.11Historical High32.47Limit Down1.22%Amplitude-3.73Historical Low1.80Dividend TTM35.91Avg Price7.05KlotAsk5.01%Div YieldTTM100Lot Size5.61KlotBid
Tibet Rhodiola Pharmaceutical Holding News
Tibet Nordicang Pharmaceutical Co., Ltd. Equity Distribution Implementation Notice for the Third Quarter of 2024
Tibet Pharmaceutical: Announcement of Tibet Nordicom Pharmaceutical Co., Ltd. on the profit distribution plan for the third quarter of 2024
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the profit distribution plan for the third quarter of 2024
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the extension of share pledges for shareholders holding 5% or more of the shares
Tibet Pharmaceutical Investor Relations Activity Record List (November)
Tibet Pharmaceutical: Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the 2024 semi-annual and third quarter results briefing
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the 2024 semi-annual and third quarter results briefing
Tibet Pharmaceutical: Tibet Nordicang Pharmaceutical Co., Ltd. Major Asset Purchase Implementation Report
Tibet Pharmaceutical: Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the completion of the implementation of Imduo\'s major asset restructuring
Tibet Pharmaceutical: Legal Opinion of Beijing Zhonglun (Shenzhen) Law Firm on the implementation of major asset restructuring of Tibet Nordicang Pharmaceutical Co., Ltd.
Tibet Pharmaceutical: Independent Financial Advisor Verification Opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the implementation of major asset purchases of Tibet Nordicang Pharmaceutical Co., Ltd.
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the completion of the implementation of Imduo\'s major asset restructuring
Legal opinion of Beijing Zhonglun (Shenzhen) Law Firm on the implementation of major asset restructuring of Tibet Nordicang Pharmaceutical Co., Ltd.
Independent financial advisory opinion of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the implementation of major asset purchases of Tibet Nordicang Pharmaceutical Co., Ltd.
Tibet Nordicang Pharmaceutical Co., Ltd. Major Asset Purchase Implementation Report
Tibet Nordicang Pharmaceutical Co., Ltd. Report for the third quarter of 2024
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on holding the 2024 semi-annual and third quarter results briefing
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on Imduo (Chinese market) obtaining approval for supplementary drug applications
Announcement of Tibet Nordicang Pharmaceutical Co., Ltd. on the progress of implementation of major asset restructuring
Tibet Pharmaceutical Investor Relations Activity Record List (August)
